Brii Biosciences Provides Update on Strategic Clinical Development Progress
- Tuesday, December 27, 2022, 7:13
- PR Newswire
- Add a comment
Topline Phase 2 data from multiple hepatitis B viral (HBV) infection functional cure combination studies expected in the first half of 2023 Initiation of Phase 2 postpartum depression (PPD) study planned for early 2023 to advance potential first-of-its-kind treatment U.S. FDA lifted…
About the Author
admin has written 20736 stories on this site.